Literature DB >> 22623698

Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

Steven Sourbron1, Wieland H Sommer, Maximilian F Reiser, Christoph J Zech.   

Abstract

PURPOSE: To evaluate the feasibility of quantifying hepatic perfusion and function by using dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging with the hepatobiliary contrast agent gadoxetic acid and a dual-inlet two-compartment uptake model.
MATERIALS AND METHODS: The study was approved by the local institutional review board, and written informed consent was obtained from all patients. Data were acquired between October 2008 and November 2009 in 24 patients with hepatic metastases from neuroendocrine tumors (13 men, 11 women; mean age, 59.8 years). DCE MR imaging was performed at 3.0 T with a standard dose of gadoxetic acid and a three-dimensional sequence, with 48 sections of data acquired every 2.2 seconds for 5 minutes. For each patient, a plasma flow map was calculated by means of deconvolution and the model was fitted to six region-of-interest curves. Results were evaluated with goodness-of-fit analysis and, in normal-appearing liver tissue, by comparing perfusion parameters with those reported in the literature. Interobserver effects in the selection of arterial and venous input functions were assessed.
RESULTS: With an arterial delay parameter, the model provided a good fit to all data. Values for arterial and venous plasma flow and extracellular volume in normal-appearing liver tissue were comparable to those in the literature. The mean intracellular uptake rate is 3.4/100/min with a standard deviation of 1.9/100/min The model also provided a good fit in all tumor data, producing high arterial flow fraction (87%) and lower uptake (1.7/100/min) . Bias due to observer-dependent differences in the selection of the input functions was negligible.
CONCLUSION: The analysis of dynamic gadoxetic acid-enhanced MR images with the dual-inlet two-compartment uptake model presents a new and practical approach for measuring arterial and venous perfusion and hepatic function in a single acquisition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623698     DOI: 10.1148/radiol.12110337

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  44 in total

Review 1.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

2.  The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function.

Authors:  Henrik Nilsson; Silja Karlgren; Lennart Blomqvist; Eduard Jonas
Journal:  HPB (Oxford)       Date:  2014-10-09       Impact factor: 3.647

3.  A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.

Authors:  Daniel Truhn; Christiane K Kuhl; Alexander Ciritsis; Alexandra Barabasch; Nils A Kraemer
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

4.  Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.

Authors:  Ying Ding; Sheng-Xiang Rao; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Hepatol Int       Date:  2014-12-06       Impact factor: 6.047

Review 5.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 6.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

Review 7.  CT and MR perfusion techniques to assess diffuse liver disease.

Authors:  Maxime Ronot; Benjamin Leporq; Bernard E Van Beers; Valérie Vilgrain
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 8.  Topics on quantitative liver magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Xiaoqi Wang; Peng Wu; Yajie Wang; Weibo Chen; Huijun Chen; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2019-11

9.  Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage.

Authors:  Krishna Juluru; Andrew H Talal; Rhonda K Yantiss; Pascal Spincemaille; Elizabeth K Weidman; Ashley E Giambrone; Sadaf Jalili; Steven P Sourbron; Jonathan P Dyke
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 10.  Multiparametric MR Imaging in Abdominal Malignancies.

Authors:  Antonio Luna; Shivani Pahwa; Claudio Bonini; Lidia Alcalá-Mata; Katherine L Wright; Vikas Gulani
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.